Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares (2020 - 2023)

Cullinan Therapeutics (CGEM) has 3 years of Treasury Shares data on record, last reported at $85.6 million in Q3 2023.

  • For Q3 2023, Treasury Shares changed N/A year-over-year to $85.6 million; the TTM value through Sep 2023 reached $85.6 million, changed N/A, while the annual FY2022 figure was $15000.0, N/A changed from the prior year.
  • Treasury Shares reached $85.6 million in Q3 2023 per CGEM's latest filing, roughly flat from $85.6 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $85.6 million in Q2 2023 and bottomed at $364000.0 in Q4 2020.
  • Average Treasury Shares over 3 years is $43.0 million, with a median of $43.0 million recorded in 2022.